Planning for phase 1/2 clinical trial initiation in Australia utilizing CYWC628 to treat diabetic foot ulcers in the first half of 2026 Improved balance sheet through multiple direct offerings; completed payments of outstanding debt HOUSTON, Feb. 24, 2026 (GLOBE NEWSWIRE) — FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 270+ patents issued and […]
Category Archives: Pr Newswire
25
Feb
Feb
REDWOOD CITY, Calif., Feb. 24, 2026 (GLOBE NEWSWIRE) — Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a clinical stage biotechnology company focused on development of briquilimab, a novel antibody therapy targeting KIT (CD117) to address mast cell driven diseases such as chronic spontaneous urticaria (CSU), chronic inducible urticaria (CIndU) and asthma, today announced that management will […]
25
Feb
Feb
PARSIPPANY, N.J. and TEL AVIV, Israel, Feb. 24, 2026 (GLOBE NEWSWIRE) — Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva’s President and CEO, will participate in the upcoming investor conferences in March as follows: UBS European Healthcare Conference Tuesday, March 3, 2026 (investor meetings only – no webcast) Leerink […]
SINGAPORE, Feb. 25, 2026 /PRNewswire/ — Reeracoen Singapore, in partnership with Rakuten Insight, has released Beyond the Paycheque: Singapore Employee Sentiment Study 2026, a new research report examining how employees in Singapore are reassessing what matters most at work amid evolving economic and workplace conditions in 2026. Based on a survey of working adults across Singapore, the study […]
Performance-linked digital asset marketplace targeting H2 2026 listing; public launch scheduled for May 1, 2026 NEW YORK, Feb. 25, 2026 /PRNewswire/ — TheSportExchange (“TSE”), operating as TSE Marketplace Ltd. in Europe, today announced its intent to pursue a direct listing of its ordinary shares on the Nasdaq or New York Stock Exchange. The company is […]
Duck Creek selection supports MAS‘ enterprise-wide technology transformation to enhance Member experiences, expand products and services, and improve efficiency SYDNEY, Feb. 25, 2026 /PRNewswire/ — New Zealand’s Medical Assurance Society (MAS) has chosen Duck Creek Technologies, the global intelligent solutions provider defining the future of general and property and casualty insurance, as their new core insurance […]
SYDNEY, Feb. 25, 2026 /PRNewswire/ — With summer road trips in full swing, BLUETTI is offering its Elite 300 portable power station bundled with the Charger 2 alternator charger at a special price of AUD $3,499. BLUETTI Elite 300 and Charger 2 Cut Recharge Downtime for Smoother Off-Grid Travel Built for caravans, campers, and motorhomes, the […]
MELBOURNE, Australia, Feb. 25, 2026 /PRNewswire/ — Fox ESS, a leading provider of renewable energy solutions, has announced a significant expansion of its energy storage capabilities in Australia with the introduction of the H3 PRO Hybrid Inverter. This latest offering is fully compatible with the EQ4800, CQ6, and EP series, positioning Fox ESS as a key […]
Pr Newswire
New Publication Demonstrates Variant-Agnostic Correlate of Protection from COVID-19 for Invivyd Monoclonal Antibody, Useful for Understanding of and Confidence in COVID-19 Antibodies
24
Feb
Feb
“A Statistical Immune Correlates of Protection Model for Predicting Efficacy from Neutralizing Antibody Titers to Establish Immunobridging of Monoclonal Antibodies for Prevention of COVID-19” was published in Infectious Diseases and Therapy This peer-reviewed analysis describes the relationship between anti-COVID monoclonal antibody (mAb) levels in patient serum and demonstrated clinical protection from multiple Omicron-virus variants in […]
Pr Newswire
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Fourth Quarter and Full Year 2025
24
Feb
Feb
― Announced positive 12-week results from the 20 mg dose cohort of the Phase 1b PIONEER trial of pociredir in sickle cell disease (SCD) ― ― 20 mg cohort demonstrated rapid and robust fetal hemoglobin (HbF) induction, with mean absolute HbF increasing by 12.2% from a baseline of 7.1% to 19.3% at Week 12, improvements […]